Greenland Mines Expands Critical Minerals Portfolio with Palladium and Rare Earth Projects

Greenland Mines Ltd (NASDAQ: GRML) is strengthening its foothold in the critical minerals sector by advancing the Skaergaard palladium-gold-platinum project in Greenland and planning the acquisition of the Sarfartoq neodymium-praseodymium (NdPr) rare earths project. The company disclosed that Skaergaard hosts a substantial palladium-equivalent resource and recently demonstrated significant metal-price leverage in an independent sensitivity study by SLR Consulting. The Sarfartoq transaction would add an advanced rare earth asset to the company's portfolio and establish Neo Performance Materials as a strategic shareholder and future offtake partner.

Greenland Mines joins a group of companies focused on strengthening Western critical minerals supply chains, including Platinum Group Metals Ltd. (NYSE American: PLG; TSX: PTM), Valterra Platinum Limited (JSE: VAL; OTC: ANGPY), Aclara Resources Inc. (TSX: ARA) and The Metals Company (NASDAQ: TMC). The company's unique position across both platinum-group metals and rare earths in a Western-aligned jurisdiction provides exposure to two strategically important mineral markets that have become increasingly important to governments, manufacturers and investors seeking alternatives to Chinese and Russian supply sources.

The Skaergaard Project, located in southeast Greenland, hosts an NI 43-101 (November 2022) Mineral Resource of 11.4 million ounces PdEq Indicated and 14.1 million ounces PdEq Inferred. Mineral Resources are not Mineral Reserves and do not have demonstrated economic viability. No preliminary economic assessment, pre-feasibility study or feasibility study has been completed on the Skaergaard Project, and there is no certainty that the Mineral Resources disclosed will be converted to Mineral Reserves or that an economically viable mining operation can be established.

Greenland Mines Ltd is a Nasdaq-listed company with two operating divisions: Mining, focused on the exploration and development of the Skaergaard Project and, subject to closing of the announced transaction, the Sarfartoq rare earth project; and Biotech, including Klotho's KLTO-202 primary indication for ALS. The company is led by an experienced team of mining, geological, biotech and capital markets professionals.

For more information about GRML, visit https://greenlandmines.com/. To view the full press release, visit https://ibn.fm/kPV46.